UHHS has been acquired by Vitapart

The shareholders of Vitapart have sold the company to UHHS.

Founded in 1989 in São Paulo, UHHS is one of the most renowned hemotherapy and cell therapy centers in Brazil. Located at Hospital Samaritano, UHHS performs more than 1,200 blood transfusions per month and is a reference in highly complex procedures, in addition to developing numerous scientific research and new medical protocols.

Founded in 2017, Vitapart was created to lead the consolidation process in the blood therapy sector in Brazil. Headquartered in Belo Horizonte, the company has already acquired numerous companies in the sector and is present in all regions of the country. The acquisition of UHHS marked Vitapart’s entry into the city of São Paulo and is part of the expansion plan in the region. In addition, the group will benefit from UHHS’s medical expertise. Vitapart is a portfolio company of the private equity fund Crescera.

One of Oaklins’ teams in Brazil acted as the exclusive financial advisor in the preparation of the sale process and due diligence, shareholders agreement, and assisted them until closing.

Service

M&A sell-side

Parties

“Thanks to the team, we conducted a transaction with tranquility and security that guaranteed us the best entry into the São Paulo market.”

Natan Lessa Goyatá

CEO, Vitapart

Talk to the deal team

Priscila Rosas

Partner

São Paulo, Brazil
Oaklins Fortezza Partners

View profile Get in touch

Related deals

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more

Armira has signed an agreement to acquire a majority stake in Viabus

Private Equity | Consumer & Retail

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Learn more

Triscan has joined APA and Riverarch to accelerate growth in the European aftermarket

Private Equity | Automotive

Triscan has joined APA and Riverarch to accelerate growth in the European aftermarket

Triscan AS, a leading provider of OE-quality automotive spare parts for the professional aftermarket in Europe, has been acquired by APA Industries, LLC, a portfolio company of Riverarch Equity Partners.

Learn more